IBOC

INTERNATIONAL BANCSHARES CORP
7 filings tracked
financialsasset managementSMALL ($300M-2B)

Signal Magnitude Chart

BULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionBULLISH | 60% | 5/7/2026 | earnings beatBULLISH | 70% | 5/7/2026 | margin expansionBULLISH | 50% | 5/7/2026 | buybackBEARISH | 40% | 5/7/2026 | regulatory actionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%
bullishMay 7

Net income increased 5.5% year-over-year to $102.2 million.

earnings beat
60%
bullishMay 7

Interest expense decreased 8.3% through disciplined deposit pricing.

margin expansion
70%
bullishMay 7

Board extended and increased repurchase program to $150 million.

buyback
50%
bearishMay 7

Uncertainty regarding Basel IV '2026 Proposals' and their impact on risk-weights.

regulatory action
40%